
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+9
Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also working on the...
Ophthalmology,immunology,scientific professionals,biosimilar medicines,drug product,cmc with strong analytics,device development,preclinical & bioanalytics,cmc regulatory affairs,project management,quality management,certified gmp analytical laboratory,biosimilar development,and anti body based covid-19 drugs
Formycon ag operates in the Biotechnology research industry.
Formycon ag's revenue is 11m - 100m
Formycon ag has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.